Table 3.
Male (n = 259 1) | Female (n = 186 1) | Total (n = 445 1) | |||||||
---|---|---|---|---|---|---|---|---|---|
Polydrug use | GPA | SD | N | GPA | SD | N | GPA | SD | N |
Non-dual use: CAN-TOB | 6.69 | 0.78 | 143 | 6.87 | 0.84 | 102 | 6.77 | 0.81 | 245 |
Concurrent use: CAN-TOB | 6.38 | 1.16 | 85 | 6.64 | 0.80 | 66 | 6.50 | 1.02 | 151 |
Simultaneous use: CAN-TOB | 6.19 | 1.46 | 10 | 6.12 | 0.25 | 4 | 6.17 | 1.22 | 14 |
Simultaneous use: CAN-TOB-ALC | 5.91 | 0.94 | 21 | 6.54 | 0.82 | 14 | 6.16 | 0.93 | 35 |
CAN: cannabis; TOB: tobacco; ALC: alcohol; GPA: grade point average; SD: standard deviation; 1 32 participants did not report their GPA.